Target type: molecularfunction
Combining with bradykinin to initiate a change in cell activity. [GOC:ai]
| Protein | Definition | Taxonomy |
|---|---|---|
| B1 bradykinin receptor | A B1 bradykinin receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P46663] | Homo sapiens (human) |
| B2 bradykinin receptor | A B2 bradykinin receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:P30411] | Homo sapiens (human) |
| Compound | Definition | Classes | Roles |
|---|---|---|---|
| amiodarone | amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias. Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. | 1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound | cardiovascular drug |
| diacetylfluorescein | |||
| coumarin 153 | coumarin 153: structure in first source | 7-aminocoumarins | fluorochrome |
| 2-butyl-6-(butylamino)-1h-benzo(de)isoquinoline-1,3(2h)-dione | |||
| coumarin 7 | coumarin 7: structure in first source | ||
| arg-3-hyp-7-phe-bradykinin | NPC 567: bradykinin receptor antagonist NPC-567 : A ten-membered oligopeptide comprising D-arginyl, L-arginyl, L-prolyl, (4R)-4-hydroxy-L-prolyl, glycyl, L-phenylalanyl, L-seryl, D-phenylalanyl, L-phenylalanyl and L-arginine residues joined in sequence. | oligopeptide | bradykinin receptor antagonist |
| kallidin, des-arg(10)- | kallidin, des-Arg(10)-: includes both L and D isomers of Phe(8) | ||
| bradykinin, leu(8)-des-arg(9)- | bradykinin, Leu(8)-des-Arg(9)-: RN given refers to (L)-isomer | ||
| bradykinin | oligopeptide | human blood serum metabolite; vasodilator agent | |
| tamoxifen | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator | |
| 3,7-dichloro-N-[3-(1-imidazolyl)propyl]-6-methoxy-1-benzothiophene-2-carboxamide | 1-benzothiophenes | ||
| fr 173657 | FR 173657: structure given in first source | ||
| fr 190997 | FR 190997: structure given in first source | ||
| bradyzide | bradyzide: structure in first source | ||
| icatibant | oligopeptide | beta-adrenergic antagonist; bradykinin receptor antagonist; peptidomimetic | |
| rmp 7 | RMP 7: a synthetic bradykinin analog; selectively increases uptake of molecular tracers in RG2 glial tumors | ||
| cp 195543 | CP 195543: a potent & selective leukotriene B4 antagonist; structure in first source | ||
| cp 105696 | CP 105696: a leukotriene B4 receptor antagonist; structure in first source | ||
| lissamine rhodamine b | lissamine rhodamine : An organic sodium salt having 4-[3,6-bis(diethylamino)xanthenium-9-yl]benzene-1,3-disulfonate as the counterion. | organic sodium salt | fluorescent probe; fluorochrome; histological dye |
| eln441958 | ELN441958: bradykinin B1 Receptor antagonist; structure in first source | ||
| nitd 609 | NITD 609: an antimalarial and coccidiostat; structure in first source |